On 5th February, AstraZeneca announced that its Phase III KESTREL clinical trial (NCT02551159) failed to achieve its primary endpoint for…
The top tweeted terms are the trending industry discussions happening on Twitter by key individuals (influencers) as tracked by the platform. Stroke– 88 mentions Links between Covid-19 and stroke, drugs…
A South Africa-based Phase IIIb observational study of Johnson & Johnson’s single-jab Covid-19 vaccine JNJ-78436735 has enrolled at least 18,000 healthcare workers out of its 500,000 target since Wednesday (17…
No new safety concerns coming out of Phase Ib trial desired to move forward Moving to Phase II, triplet needs to show superiority over rival Targeting specific mutations important for…
Companies and organisations continue to report trial disruptions due to the Covid-19 pandemic, which includes delayed initiation, delayed enrollment, and slow enrollment. As the number of Covid-19 cases and deaths…
As of 15 February, the likelihood of approval (LoA) for Pfizer’s Rapamune (sirolimus) for Sturge-Weber Syndrome (SWS) rose 15 points, according to GlobalData’s LoA data. The score was based on published results…
Arcus Biosciences’ Phase Ib/II adenosine receptor antagonist AB928 (etrumadenant) has a logical mechanism in first-line (1L) pancreatic ductal adenocarcinoma (PDAC), experts said. But they noted several issues that need to be…